MC1R and melanoma: Biocompatible ultrasmall fluorescent core–shell silica nanoparticles (C′ dots, diameter ∼6.0 nm) have been engineered to target the melanocortin-1 receptor expressed on melanoma through α melanocyte-stimulating hormone peptides attached to the C′ dot surface.